1. Cys-Loop Receptor Channel Blockers Also Block GLIC
- Author
-
Hans-Georg Breitinger, Mona Alqazzaz, Sarah C. R. Lummis, Andrew J. Thompson, and Kerry L. Price
- Subjects
Cysteine Loop Ligand-Gated Ion Channel Receptors ,Gloeobacter ,Sesterterpenes ,biology ,Chemistry ,GABAA receptor ,GLIC ,Biophysics ,Plasma protein binding ,biology.organism_classification ,Rimantadine ,Biochemistry ,Bacterial Proteins ,Docking (molecular) ,Cellular Biophysics and Electrophysiology ,Humans ,Picrotoxin ,Binding site ,Ion Channel Gating ,Ion channel ,Hexachlorocyclohexane ,Protein Binding - Abstract
The Gloeobacter ligand-gated ion channel (GLIC) is a bacterial homolog of vertebrate Cys-loop ligand-gated ion channels. Its pore-lining region in particular has a high sequence homology to these related proteins. Here we use electrophysiology to examine a range of compounds that block the channels of Cys-loop receptors to probe their pharmacological similarity with GLIC. The data reveal that a number of these compounds also block GLIC, although the pharmacological profile is distinct from these other proteins. The most potent compound was lindane, a GABAA receptor antagonist, with an IC50 of 0.2 μM. Docking studies indicated two potential binding sites for this ligand in the pore, at the 9′ or between the 0′ and 2′ residues. Similar experiments with picrotoxinin (IC50 = 2.6 μM) and rimantadine (IC50 = 2.6 μM) reveal interactions with 2′Thr residues in the GLIC pore. These locations are strongly supported by mutagenesis data for picrotoxinin and lindane, which are less potent in a T2′S version of GLIC. Overall, our data show that the inhibitory profile of the GLIC pore has considerable overlap with those of Cys-loop receptors, but the GLIC pore has a unique pharmacology.
- Published
- 2011
- Full Text
- View/download PDF